Outcome of the meeting of the Board of Directors held on Wednesday, June 04, 2025
Price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Awaiting price reaction for this filing.
The Board of Directors of Shukra Pharmaceuticals Ltd met on June 4, 2025 and recommended a Final Dividend of Rs. 0.01 per equity share (1%) on shares of face value Rs. 1 each for the financial year 2024-25. The dividend is subject to shareholder approval at the upcoming Annual General Meeting and applicable tax deduction. The board also reviewed other routine business matters. The meeting lasted 30 minutes, from 4:00 p.m. to 4:30 p.m.
The dividend is nominal at just 1% on face value (Rs. 0.01 per share) and is unlikely to have any meaningful impact on shareholder returns or stock price. It reflects a token payout rather than a significant capital return event.